LAMEA Dermal Fillers Market Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2025

The LAMEA dermal fillers market is estimated to grow at a CAGR of 7.4% during the forecast period. RoW countries include Brazil, Mexico and Colombia, Saudi Arabia and the United Arab Emirates (UAE). RoW dermal fillers market is estimated to grow significantly during the forecast period owing to the rising demand for non-surgical procedures coupled with the rising availability of filler options available in the Brazilian market. As a result, the companies are looking to expand the availability of their dermal fillers in these countries. For instance, in January 2018, Sinclair Pharma plc announced that it has received regulatory approval of Ellansé by ANVISA in Brazil. Brazil is considered as one of the major aesthetic dermatology markets with a considerable rise in the injectable procedures reported in 2017.

Get Sample Copy of LAMEA Dermal Fillers Market at: https://www.omrglobal.com/request-sample/lamea-dermal-fillers-market

Key players operating in the LAMEA dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA.

This is representing a significant demand for non-surgical cosmetic procedures in these countries. For instance, as per ISAPS, in Brazil, the number of injectable procedures was 677,765 in 2017, whereas, in Columbia, it was 125,350 in 2017. Due to such a rise in injectable procedures, a significant availability of plastic surgeons has been witnessed in 2017. For instance, as per the ISAPS, in 2017, the estimated number of plastic surgeons in Brazil was 5,500, while, the estimated number of plastic surgeons in Colombia was 1,000. The demand for this injectable procedure is anticipated to grow significantly in the region coupled with increasing disposable income across the countries, such as Saudi Arabia and UAE, which in turn, will likely drive the demand for dermal filler treatment in the region.

For More Information get A full report of LAMEA Dermal Fillers is available at: https://www.omrglobal.com/industry-reports/lamea-dermal-fillers-market

The LAMEA dermal fillers market can be segmented based on application, type, and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.

LAMEA Dermal Fillers Market Segmentation

LAMEA Dermal Fillers Market by Application

• Face-Lift
• Lip Treatment/Enhancement
• Facial Line Correction Treatment
• Others (Acne Scar Treatment)

LAMEA Dermal Fillers Market by Type

• Collagen Fillers
• Ploy-L-Lactic Acid (PLLA)
• Hyaluronic Acid (HA)
• Calcium Hydroxylapatite (CaHA)
• Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA)

LAMEA Dermal Fillers Market by End-User

• Dermatology Clinics
• Hospitals

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/lamea-dermal-fillers-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.